Nanomedicine for Diagnosis and Treatment of Atherosclerosis
J Cheng, H Huang, Y Chen, R Wu - Advanced Science, 2023 - Wiley Online Library
With the changing disease spectrum, atherosclerosis has become increasingly prevalent
worldwide and the associated diseases have emerged as the leading cause of death. Due …
worldwide and the associated diseases have emerged as the leading cause of death. Due …
Nanomedicine approaches for advanced diagnosis and treatment of atherosclerosis and related ischemic diseases
B Hu, KO Boakye‐Yiadom, W Yu… - Advanced …, 2020 - Wiley Online Library
Cardiovascular diseases (CVDs) remain one of the major causes of mortality worldwide. In
response to this and other worldwide health epidemics, nanomedicine has emerged as a …
response to this and other worldwide health epidemics, nanomedicine has emerged as a …
Atherosclerosis and nanomedicine potential: current advances and future opportunities
F Jiang, Y Zhu, C Gong, X Wei - Current Medicinal Chemistry, 2020 - ingentaconnect.com
Atherosclerosis is the leading inducement of cardiovascular diseases, which ranks the first
cause of global deaths. It is an arterial disease associated with dyslipidemia and changes in …
cause of global deaths. It is an arterial disease associated with dyslipidemia and changes in …
Nanomedicine in the diagnosis and treatment of atherosclerosis-a systematic review
K Vaidyanathan… - … Disorders-Drug Targets …, 2017 - ingentaconnect.com
Background: Atherosclerosis is a chronic inflammatory condition causing very high morbidity
and mortality. It is characterized by accumulation of plaques within arteries. Nanomedicine is …
and mortality. It is characterized by accumulation of plaques within arteries. Nanomedicine is …
[HTML][HTML] Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective
A Nakhlband, M Eskandani, Y Omidi, N Saeedi… - BioImpacts …, 2018 - ncbi.nlm.nih.gov
An external file that holds a picture, illustration, etc. Object name is bi-8-59-g004. jpg
Introduction: Cardiovascular diseases (CVDs) is recognized as the leading cause of …
Introduction: Cardiovascular diseases (CVDs) is recognized as the leading cause of …
[PDF][PDF] Emerging nanoparticles in the diagnosis of atherosclerosis
T Kataria, MS Hussain, G Kaur… - International Journal of …, 2021 - researchgate.net
Throughout the last few decades, cardiovascular research has substantially advanced our
awareness of the atherosclerotic process, the molecular processes underlying the disease …
awareness of the atherosclerotic process, the molecular processes underlying the disease …
Nanomaterials as novel cardiovascular theranostics
Cardiovascular diseases (CVDs) are a group of conditions associated with heart and blood
vessels and are considered the leading cause of death globally. Coronary heart disease …
vessels and are considered the leading cause of death globally. Coronary heart disease …
Nanomedicine for the prevention, treatment and imaging of atherosclerosis
C Psarros, R Lee, M Margaritis, C Antoniades - Maturitas, 2012 - Elsevier
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in developed
countries, with an increasing prevalence due to an aging population. The pathology …
countries, with an increasing prevalence due to an aging population. The pathology …
Nanotechnology translation in vascular diseases: From design to the bench
Y Zhou, T Yue, Y Ding, H Tan, J Weng… - Wiley …, 2024 - Wiley Online Library
Atherosclerosis is a systemic pathophysiological condition contributing to the development
of majority of polyvascular diseases. Nanomedicine is a novel and rapidly developing …
of majority of polyvascular diseases. Nanomedicine is a novel and rapidly developing …
New insights to atherosclerosis management: Role of nanomaterials
Atherosclerosis is a sort of chronic inflammatory disease mainly caused by the accumulation
of lipoproteins on the blood vessel walls. Many cardiovascular diseases with high mortality …
of lipoproteins on the blood vessel walls. Many cardiovascular diseases with high mortality …